Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

PROPANTHELINE BROMIDE

PROPANTHELINE BROMIDE

Standard Dose
15MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview PROPANTHELINE BROMIDE is listed in Drugs@FDA under application 088377 (ANDA).

Marketing status: Discontinued Active ingredient PROPANTHELINE BROMIDE Form and strength TABLET;ORAL - 15MG Sponsor PAR PHARM Submission history Latest submission status date: 1993-10-25 00:00:00.

Structured Monograph

Clinical summary

Approval overview PROPANTHELINE BROMIDE is listed in Drugs@FDA under application 088377 (ANDA). Marketing status: Discontinued Active ingredient PROPANTHELINE BROMIDE Form and strength TABLET;ORAL - 15MG Sponsor PAR PHARM Submission history Latest submission status date: 1993-10-25 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.